Avy Violari

Summary

Affiliation: University of Cape Town
Country: South Africa

Publications

  1. ncbi Early antiretroviral therapy and mortality among HIV-infected infants
    Avy Violari
    Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa
    N Engl J Med 359:2233-44. 2008
  2. ncbi Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study
    Clotilde Hainline
    Department of Paediatrics and Child Health and Children s Infectious Diseases Clinical Research Unit KID CRU, Tygerberg Children s Hospital and Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa
    BMC Res Notes 4:448. 2011
  3. ncbi Utility of clinical parameters to identify HIV infection in infants below ten weeks of age in South Africa: a prospective cohort study
    Heather B Jaspan
    Children s Infectious Diseases Clinical Research Unit, Department of Paediatrics and Child Health and Centre for Infectious Diseases, Stellenbosch University, Tygerberg, South Africa
    BMC Pediatr 11:104. 2011
  4. ncbi Inferior quantitative and qualitative immune responses to pneumococcal conjugate vaccine in infants with nasopharyngeal colonization by Streptococcus pneumoniae during the primary series of immunization
    Shabir A Madhi
    University of the Witwatersrand, Department of Science and Technology National Research Foundation Vaccine Preventable Diseases and Respiratory and Meningeal Pathogens Research Unit, Johannesburg, South Africa
    Vaccine 29:6994-7001. 2011
  5. ncbi Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children
    Avy Violari
    Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa
    N Engl J Med 366:2380-9. 2012
  6. ncbi Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants
    Shabir A Madhi
    Department of Science National Research Foundation, Vaccine Preventable Diseases, University of the Witwatersrand, Johannesburg, South Africa
    J Infect Dis 202:355-61. 2010
  7. ncbi Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children
    Shabir A Madhi
    Department of Science and Technology National Research Foundation Vaccine Preventable Diseases and the Medical Research Council Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa
    N Engl J Med 365:21-31. 2011
  8. ncbi Combining PMTCT with active case finding for tuberculosis
    Paula B N Kali
    Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa
    J Acquir Immune Defic Syndr 42:379-81. 2006
  9. ncbi Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progression
    Isaac Choge
    AIDS Virus Research Unit, National Institute for Communicable Diseases, Johannesburg, South Africa
    AIDS Res Hum Retroviruses 22:458-65. 2006
  10. ncbi A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers
    Glenda E Gray
    Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg South Africa
    AIDS 19:1289-97. 2005

Collaborators

Detail Information

Publications10

  1. ncbi Early antiretroviral therapy and mortality among HIV-infected infants
    Avy Violari
    Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa
    N Engl J Med 359:2233-44. 2008
    ..We investigated antiretroviral-treatment strategies in the Children with HIV Early Antiretroviral Therapy (CHER) trial...
  2. ncbi Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study
    Clotilde Hainline
    Department of Paediatrics and Child Health and Children s Infectious Diseases Clinical Research Unit KID CRU, Tygerberg Children s Hospital and Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa
    BMC Res Notes 4:448. 2011
    ..abstract:..
  3. ncbi Utility of clinical parameters to identify HIV infection in infants below ten weeks of age in South Africa: a prospective cohort study
    Heather B Jaspan
    Children s Infectious Diseases Clinical Research Unit, Department of Paediatrics and Child Health and Centre for Infectious Diseases, Stellenbosch University, Tygerberg, South Africa
    BMC Pediatr 11:104. 2011
    ..Receiver Operating Characteristic (ROC) curves were compiled using combinations of clinical findings...
  4. ncbi Inferior quantitative and qualitative immune responses to pneumococcal conjugate vaccine in infants with nasopharyngeal colonization by Streptococcus pneumoniae during the primary series of immunization
    Shabir A Madhi
    University of the Witwatersrand, Department of Science and Technology National Research Foundation Vaccine Preventable Diseases and Respiratory and Meningeal Pathogens Research Unit, Johannesburg, South Africa
    Vaccine 29:6994-7001. 2011
    ....
  5. ncbi Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children
    Avy Violari
    Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa
    N Engl J Med 366:2380-9. 2012
    ..Regardless of whether there has been prior exposure to nevirapine, the performance of nevirapine versus ritonavir-boosted lopinavir in young children has not been rigorously established...
  6. ncbi Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants
    Shabir A Madhi
    Department of Science National Research Foundation, Vaccine Preventable Diseases, University of the Witwatersrand, Johannesburg, South Africa
    J Infect Dis 202:355-61. 2010
    ..Nevertheless, M-/I- infants had superior OPA responses, compared with those in HIV+/ART+ infants, who in turn had better OPA responses, compared with those in HIV+/ART- infants...
  7. ncbi Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children
    Shabir A Madhi
    Department of Science and Technology National Research Foundation Vaccine Preventable Diseases and the Medical Research Council Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa
    N Engl J Med 365:21-31. 2011
    ..We conducted a double-blind, randomized, placebo-controlled trial of preexposure isoniazid prophylaxis against tuberculosis in HIV-infected children and uninfected children exposed to HIV during the perinatal period...
  8. ncbi Combining PMTCT with active case finding for tuberculosis
    Paula B N Kali
    Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa
    J Acquir Immune Defic Syndr 42:379-81. 2006
    ..We conclude that rates of TB in HIV-infected pregnant women are high, and screening for TB during routine antenatal care should be implemented in high HIV-prevalence settings...
  9. ncbi Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progression
    Isaac Choge
    AIDS Virus Research Unit, National Institute for Communicable Diseases, Johannesburg, South Africa
    AIDS Res Hum Retroviruses 22:458-65. 2006
    ..Similar to adults, CXCR4 usage was uncommon among HIV-1 subtype C isolates from pediatric infections...
  10. ncbi A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers
    Glenda E Gray
    Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg South Africa
    AIDS 19:1289-97. 2005
    ..Where women do not access antenatal care or HIV testing, postexposure prophylaxis to the infant may be an important preventative strategy...